CS MEDICA brings forward publication of interim report for Q3
CS MEDICA A/S (“CS MEDICA” or the “Company”) has decided to bring forward the publication of its interim report for the third quarter to Friday 12 August 2022.
CS MEDICA’s interim report for quarter 3 2022 will be published on Friday 12 August 2022, instead of Saturday 13 August 2022 as previously communicated.
For more information about CS MEDICA, please contact:
Gitte Lund Henriksen, CFO
Phone: + (45) 2774 2280
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.